RÉSUMÉ
Animals frequently eat less after a test-article treatment in nonclinical toxicological studies, and it can be difficult to distinguish test article-derived toxicities from secondary changes related to this reduced food intake. Therefore, in this study, we restricted the food intake of cynomolgus monkeys (Cambodian, male, n=2 or 3, 48 ± 3 months old) to 25% of the control for two weeks and evaluated the effects on toxicological parameters (general conditions, body weight, electrocardiography, urinalysis, hematology, blood chemistry, bone marrow analysis, pathological examination). After 2 weeks, the monkeys exhibited decreases in bone marrow erythropoiesis (e.g., decreases in reticulocytes and bone marrow erythrocytes), as well as glycogenesis induction (e.g., increase in aspartate aminotransferase (AST)) and malnutrition (e.g., decrease in triglyceride and systemic adipocytes atrophy). Additionally, histopathological analysis revealed granuloma and inflammatory cell infiltration in coronary fat, which had never been found in previous food restriction studies using other animal species. These findings will enable researchers to more accurately evaluate the toxicological risks of test articles that simultaneously induce food intake reduction.
Sujet(s)
Consommation alimentaire , Aliments , Mâle , Animaux , Macaca fascicularis , Poids , ÉlectrocardiographieRÉSUMÉ
In new drug development, cells or animals are treated with the selected candidate compound to confirm its efficacy and safety in nonclinical studies. Clinical laboratory tests are carried out using samples from experimental animals in these studies. The clinical laboratory test method validation in nonclinical fields should be conducted keeping in mind that the circumstances differ from those in clinical settings. However, the validation procedures have not been systematically integrated into any standard. The considerations in this paper set out systematically practical guidance for the validation of quantitative analytical methods for fluid samples collected from animal studies, for the purpose of ensuring that laboratory test method validation is conducted in nonclinical fields at an enough level.
Sujet(s)
Techniques de laboratoire clinique , Laboratoires cliniques , Animaux , Évaluation préclinique de médicament/méthodes , Développement de médicament , Plan de rechercheRÉSUMÉ
Dioxins are a group of structurally related chemicals that persist in the environment. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most toxic congener, is a suspected risk factor for cardiac diseases in humans. TCDD induces signs of cardiotoxicity in various animals. Mouse models of TCDD exposure suggest cardiotoxicity phenotypes develop differently depending on the timing and time-course of exposure. In order to clarify and characterize the TCDD-induced cardiotoxicity in the developing period, we utilized mouse pups exposed to TCDD. One day after delivery, groups of nursing C57BL/6J dams were orally administered TCDD at a dose of 0 (Control), 20 (TCDD-20), or 80 µg/kg (TCDD-80) body weight (BW). On postnatal days (PNDs) 7 and 21, pups' hearts were examined by histological and gene expression analyses. The TCDD-80 group was found to have a left ventricular remodeling on PND 7, and to develop heart hypertrophy on PND 21. It was accompanied by fibrosis and increased expression of associated genes, such as those for atrial natriuretic peptide (ANP), ß-myosin heavy chain (ß-MHC), and endothelin-1 (ET-1). These results revealed that TCDD directly induces cardiotoxicity in the postnatal period represented by progressive hypertrophy in which ANP, ß-MHC, and ET-1 have potentials to mediate the cardiac hypertrophy and heart failure.
Sujet(s)
Cardiomégalie/induit chimiquement , Cardiomégalie/génétique , Cardiotoxicité , Polluants environnementaux/métabolisme , Polluants environnementaux/toxicité , Défaillance cardiaque/induit chimiquement , Défaillance cardiaque/génétique , Lactation/métabolisme , Dibenzodioxines polychlorées/métabolisme , Dibenzodioxines polychlorées/toxicité , Administration par voie orale , Animaux , Animaux nouveau-nés , Facteur atrial natriurétique/génétique , Facteur atrial natriurétique/métabolisme , Endothéline-1/génétique , Endothéline-1/métabolisme , Polluants environnementaux/administration et posologie , Femelle , Expression des gènes/effets des médicaments et des substances chimiques , Humains , Souris de lignée C57BL , Modèles animaux , Chaînes lourdes de myosine/génétique , Chaînes lourdes de myosine/métabolisme , Dibenzodioxines polychlorées/administration et posologie , GrossesseRÉSUMÉ
Strangles is a commonly diagnosed and important infectious disease of equids worldwide, caused by Streptococcus equi subsp. equi. We determined the SeM genotypes of S. equi isolated from imported horses at the Japanese border within the past 8 years, which allowed us to classify 12 strains isolated from these horses from each exporter into four allelic groups. These alleles were different from the alleles of past isolates found in Japan. Furthermore, four strains classified into the same allele were isolated from horses from one exporter over several years. In this study, S. equi isolates from different exporters had different SeM alleles. Attention to the hygiene status of farms will be necessary to prevent the incursion of strangles.
Sujet(s)
Maladies des chevaux/microbiologie , Infections à streptocoques/médecine vétérinaire , Streptococcus equi/génétique , Animaux , Protéines bactériennes/génétique , Maladies des chevaux/épidémiologie , Equus caballus , Japon/épidémiologie , Lymphadénite/microbiologie , Lymphadénite/médecine vétérinaire , Infections à streptocoques/microbiologie , Streptococcus equi/isolement et purificationRÉSUMÉ
The aryl hydrocarbon receptor (AHR) plays a major role in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced toxicity phenotypes. TCDD bound to AHR elicits both genomic action in which target genes are transcriptionally upregulated and nongenomic action in which cytosolic phospholipase A2α (cPLA2α) is rapidly activated. However, how either of these actions, separately or in combination, induces toxicity phenotypes is largely unknown. In this study, we used AHRnls/nls mice as a model in which AHR was mutated to lack nuclear translocation sequence (NLS), and AHRd/- mice as the corresponding control. Using this model, we studied TCDD-induced alterations in cPLA2α activation and related factors because of the pivotal roles of cPLA2α both in AHR's nongenomic action and in regulation of causative genes of TCDD-induced hydronephrosis. Dams were orally administered TCDD at a dose of 300 µg/kg body weight on postnatal day 1, and pups subsequently exposed to TCDD via milk were examined for gene expression on PND 7 and for histological changes on PND 14. The activation of the AHR genomic action and hydronephrosis onset were observed in the control group but not in the AHRnls/nls group. An ex vivo experiment using peritoneal macrophages exposed to 100 nM TCDD resulted in rapid activation of cPLA2α, an indicator of the nongenomic action, only in the control group but not in the AHRnls/nls group. These results indicated that an NLS is required for the AHR's genomic and nongenomic actions.
Sujet(s)
Facteurs de transcription à motif basique hélice-boucle-hélice/génétique , Group IV phospholipases A2/métabolisme , Hydronéphrose/induit chimiquement , Dibenzodioxines polychlorées/toxicité , Récepteurs à hydrocarbure aromatique/génétique , Animaux , Femelle , Hydronéphrose/génétique , Macrophages péritonéaux/effets des médicaments et des substances chimiques , Macrophages péritonéaux/métabolisme , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Dibenzodioxines polychlorées/administration et posologie , Tératogènes/toxicité , Facteurs tempsRÉSUMÉ
Prostaglandin E2 (PGE2) is a critical factor in the pathogenesis of dioxin-induced neonatal hydronephrosis. Since the PGE2 receptor has four subtypes, EP1 - EP4, this study was aimed to challenge the hypothesis that at least one of the four subtypes is responsible for the pathogenesis of dioxin-induced hydronephrosis. To this end, we used mouse pups, with a C57BL/6 J background, genetically lacking EP1, EP2, or EP3, and wild-type pups in whom EP4 was suppressed by administering ONO-AE3-208 (ONO), an EP4 antagonist, from postnatal day 1 (PND 1) to PND 13. To expose the pups to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via lactation, the dams were administered TCDD at an oral dose of 20 µg/kg on PND 1. The pups' urine and kidneys were collected on PND 14 for urinalysis and histological examination, respectively. We found that the incidence of hydronephrosis was 80% in the EP1+/+ group, but was markedly reduced to 28.6% in the EP1-/- group despite the fact that PGE2 concentration in the urine was similarly increased in the both groups. In contrast, the incidence of hydronephrosis was 80% and 100% in the EP2+/+ and EP2-/-groups, respectively, and 88.9% and 100% in the EP3+/+ and EP3-/- groups, respectively. With regard to EP4, the incidence of hydronephrosis in vehicle (saline)-treated groups and ONO-treated was 88.9% and 100%, respectively. Therefore, we concluded that among PGE2 receptor subtypes, EP1 plays a predominant role in the onset of TCDD-induced neonatal hydronephrosis in mouse pups.
Sujet(s)
Hydronéphrose/induit chimiquement , Hydronéphrose/physiopathologie , Dibenzodioxines polychlorées/toxicité , Sous-type EP2 des récepteurs des prostaglandines E/physiologie , Animaux , Animaux nouveau-nés , Femelle , Mâle , Souris , Souris de lignée C57BL , Sous-type EP2 des récepteurs des prostaglandines E/génétiqueRÉSUMÉ
Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces a variety of toxicities upon binding of TCDD to aryl hydrocarbon receptor. Although this binding upregulates the synthesis of prostaglandins and their related lipid mediators via cytosolic phospholipase A2α (cPLA2α), toxicological significance of this signaling pathway remains elusive. Herein, we investigated the roles of cPLA2α in TCDD toxicities using cPLA2α-null mice. In a first set of experiments, pregnant mice were orally administered TCDD at a dose of 40 µg/kg on gestation day (GD) 12.5, and fetuses were collected on GD 18 for subsequent analyses. The number of live male fetuses of cPLA2α-null type was significantly less than that of wild-type in TCDD-exposed litters. TCDD-induced hydronephrosis was more severe in wild-type fetuses than in cPLA2α-null fetuses regardless of sex, and kidney expression levels of the inflammatory cytokines interleukin-1ß and tumor necrosis factor-α were increased in a cPLA2α-dependent manner in TCDD-exposed fetuses. In a second set of experiments, following intraperitoneal administration of TCDD at 50 µg/kg, body weight of the male adult mice was decreased within 2 days in wild-type mice but was not changed in cPLA2α-null mice. In addition, TCDD-induced lipid accumulation in the livers of cPLA2α-null mice was at an intermediate level compared with TCDD-exposed wild-type and vehicle-control mice. In conclusion, the present results show that cPLA2α is involved in TCDD-induced body weight loss, lipid accumulation in the liver, fetal hydronephrosis, and cytokine gene expression, and that the molecular basis of TCDD toxicity differs considerably between target tissues and life stages.
Sujet(s)
Group IV phospholipases A2/métabolisme , Rein/effets des médicaments et des substances chimiques , Foie/effets des médicaments et des substances chimiques , Dibenzodioxines polychlorées/toxicité , Administration par voie orale , Animaux , Femelle , Foetus/effets des médicaments et des substances chimiques , Group IV phospholipases A2/génétique , Hydronéphrose/induit chimiquement , Injections péritoneales , Rein/anatomopathologie , Foie/anatomopathologie , Mâle , Exposition maternelle/effets indésirables , Souris , Souris de lignée C57BL , Souris knockout , Grossesse , Tératogènes/toxicité , Perte de poidsRÉSUMÉ
Hydronephrosis is a commonly found disease state characterized by the dilation of renal calices and pelvis, resulting in the loss of kidney function in the severest cases. A generally accepted etiology of hydronephrosis involves the obstruction of urine flow along the urinary tract. In the recent years, we have developed a mouse model of hydronephrosis induced by lactational exposure to dioxin and demonstrated a lack of anatomical obstruction in this model. We also showed that prostaglandin E2 synthesis system plays a critical role in the onset of hydronephrosis. In the present study, we found that neonatal hydronephrosis was not likely to be associated with functional obstruction (impaired peristalsis) but was found to be associated with polyuria and low urine osmolality with the downregulation of proteins involved in the urine concentrating process. The administration of an antidiuretic hormone analog to the dioxin-exposed pups not only suppressed the increased urine output but also decreased the incidence and severity of hydronephrosis. In contrast to the case in pups, administration of dioxin to adult mice failed to induce polyuria and upregulation of prostaglandin E2 synthesis system, and the adult mice were resistant to develop hydronephrosis. These findings suggest the possibility that polyuria could induce hydronephrosis in the absence of anatomical or functional obstruction of the ureter. It is concluded that the present animal model provides a unique example of polyuria-associated type of hydronephrosis, suggesting a need to redefine this disease state.
Sujet(s)
Hydronéphrose/induit chimiquement , Dibenzodioxines polychlorées , Polyurie/induit chimiquement , Voies urinaires/effets des médicaments et des substances chimiques , Animaux , Dinoprostone/métabolisme , Modèles animaux de maladie humaine , Femelle , Hydronéphrose/traitement médicamenteux , Hydronéphrose/métabolisme , Lactation , Mâle , Souris , Polyurie/traitement médicamenteux , Polyurie/métabolisme , Voies urinaires/métabolismeRÉSUMÉ
Pyrrocidine A is a known antimicrobial compound produced by endophytic fungi and has a unique 13-membered macrocyclic alkaloid structure with an α,ß-unsaturated carbonyl group. We have previously reported that pyrrocidine A shows potent cytotoxicity against human acute promyelocytic leukemia HL60 cells, and the activity is 70-fold higher than that of pyrrocidine B which is the analog lacking the α,ß-unsaturated carbonyl group. Pyrrocidine A induced nuclear condensation, DNA fragmentation and caspase activation in HL60 cells. Since the DNA fragmentation was suppressed by pretreatment with the pan-caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (z-VAD-fmk), caspase-mediated apoptosis contributes to pyrrocidine A-induced cytotoxicity. JFCR39 human cancer cells panel indicated that the mechanism of action of pyrrocidine A is different from other clinical anticancer drugs, and this compound broadly inhibited the growth of various cancer cell lines. The apoptosis induction by pyrrocidine A was suppressed by both N-acetyl-l-cysteine (NAC) and glutathione, both of which are thiol-containing antioxidants. Furthermore, pyrrocidine A directly bound to N-acetyl-l-cysteine methyl ester (NACM) through the Michael-type addition at the α,ß-unsaturated carbonyl group and was detected by HPLC and liquid chromatography-ESI-tandem MS (LC-ESI-MS/MS) analyses. This indicates that this moiety is crucial for the potent apoptosis-inducing activity of pyrrocidine A.
Sujet(s)
Anti-infectieux/pharmacologie , Antinéoplasiques/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Composés pontés/pharmacologie , Pyrrolidones/pharmacologie , Acétylcystéine/pharmacologie , Chlorométhyl cétones d'acides aminés/pharmacologie , Inhibiteurs des caspases/pharmacologie , Fragmentation de l'ADN/effets des médicaments et des substances chimiques , Cellules HL-60 , Humains , Hypocreales/composition chimique , Oligopeptides/pharmacologie , Espèces réactives de l'oxygène , Spectrométrie de masse en tandemRÉSUMÉ
Halogenated aromatic hydrocarbons, including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), are known to cause severe heart defects in avian species. However, the mechanism of TCDD-induced chick cardiovascular toxicity is unclear. In this study, we investigated cyclooxygenase-2 (COX-2) as a possible mechanism of TCDD-induced cardiotoxicity. Fertile chicken eggs were injected with TCDD and a COX-2 selective inhibitor, NS398, and we investigated chick heart failure on day 10. We found that the chick heart to body weight ratio and atrial natriuretic factor mRNA expression were increased, but this increase was abolished with treatment of NS398. In addition, the morphological abnormality of an enlarged ventricle resulting from TCDD exposure was also abolished with co-treatment of TCDD and NS398. Our results suggested that TCDD-induced chick heart defects are mediated via the nongenomic pathway and that they do not require the genomic pathway.
Sujet(s)
Antidotes/usage thérapeutique , Inhibiteurs de la cyclooxygénase 2/usage thérapeutique , Polluants environnementaux/antagonistes et inhibiteurs , Cardiopathies congénitales/prévention et contrôle , Coeur/effets des médicaments et des substances chimiques , Dibenzodioxines polychlorées/antagonistes et inhibiteurs , Tératogènes/toxicité , Animaux , Lignées consanguines d'animaux , Aryl hydrocarbon hydroxylases/génétique , Aryl hydrocarbon hydroxylases/métabolisme , Facteur atrial natriurétique/génétique , Facteur atrial natriurétique/métabolisme , Protéines aviaires/antagonistes et inhibiteurs , Protéines aviaires/génétique , Protéines aviaires/métabolisme , Embryon de poulet , Cyclooxygenase 2/composition chimique , Cyclooxygenase 2/génétique , Cyclooxygenase 2/métabolisme , Développement embryonnaire/effets des médicaments et des substances chimiques , Polluants environnementaux/toxicité , Régulation de l'expression des gènes codant pour des enzymes/effets des médicaments et des substances chimiques , Coeur/embryologie , Cardiopathies congénitales/induit chimiquement , Cardiopathies congénitales/embryologie , Cardiopathies congénitales/métabolisme , Myocarde/enzymologie , Myocarde/métabolisme , Myocarde/anatomopathologie , Nitrobenzènes/usage thérapeutique , Taille d'organe/effets des médicaments et des substances chimiques , Dibenzodioxines polychlorées/toxicité , Répartition aléatoire , Sulfonamides/usage thérapeutique , Tératogènes/composition chimiqueRÉSUMÉ
Hydronephrosis is a common disease characterized by dilation of the renal pelvis and calices, resulting in loss of kidney function in the most severe cases. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces nonobstructive hydronephrosis in mouse neonates through upregulation of prostaglandin E2 (PGE2) synthesis pathway consisting of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1) by a yet unknown mechanism. We here studied possible involvement of cytosolic phospholipase A2α (cPLA2α) in this mechanism. To this end, we used a cPLA2α-null mouse model and found that cPLA2α has a significant role in the upregulation of the PGE2 synthesis pathway through a noncanonical pathway of aryl hydrocarbon receptor. This study is the first to demonstrate the predominant role of cPLA2α in hydronephrosis. Elucidation of the pathway leading to the onset of hydronephrosis using the TCDD-exposed mouse model will deepen our understanding of the molecular basis of nonobstructive hydronephrosis in humans.
Sujet(s)
Dinoprostone/biosynthèse , Group IV phospholipases A2/métabolisme , Hydronéphrose/anatomopathologie , Animaux , Cyclooxygenase 2/biosynthèse , Cytochrome P-450 CYP1A1/génétique , Modèles animaux de maladie humaine , Femelle , Expression des gènes , Group IV phospholipases A2/génétique , Hydronéphrose/induit chimiquement , Protéine-1 de liaison aux IGF/génétique , Intramolecular oxidoreductases/biosynthèse , Intramolecular oxidoreductases/génétique , Rein/anatomopathologie , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Dibenzodioxines polychlorées , Prostaglandin-E synthases , ARN messager/biosynthèse , Récepteurs à hydrocarbure aromatique/génétique , Récepteurs à hydrocarbure aromatique/métabolisme , Transduction du signal/génétique , Régulation positiveRÉSUMÉ
There are two arylhydrocarbon receptor (AhR) isoforms in birds, AhR1 and AhR2. The varying sensitivity of AhR is reported to be related to two critical amino acids at positions 325 and 381 in the AhR1 ligand-binding domain. In this study, seven avian species whose in vivo dioxin sensitivity was known, and 13 species with no data regarding their in vivo dioxin sensitivity were examined. The two critical amino acids in the ligand-binding domain were investigated in avian species, and the results were compared with the taxonomy or phylogenetic trees for the bird AhR proteins. We found that the two critical amino acids did not correlate with the taxonomy or phylogeny of these proteins, suggesting that dioxin sensitivity was independent of taxonomy.
Sujet(s)
Oiseaux/génétique , Dioxines/toxicité , Récepteurs à hydrocarbure aromatique/génétique , Récepteurs à hydrocarbure aromatique/métabolisme , Acides aminés/génétique , Animaux , Séquence nucléotidique , Sites de fixation/génétique , Amorces ADN/génétique , ADN complémentaire/génétique , Fonctions de vraisemblance , Modèles génétiques , Données de séquences moléculaires , Phylogenèse , Analyse de séquence d'ADN , Spécificité d'espèceRÉSUMÉ
A bisabolane sesquiterpene endoperoxide compound, 3,6-epidioxy-1,10-bisaboladiene (EDBD), was isolated from edible wild plants grown in the northern area of Japan, Cacalia delphiniifolia and Cacalia hastata, using a mutant yeast (cdc2-1 rad9Δ). It showed cytotoxicity at IC(50) = 3.4 µM and induced apoptosis against the human promyelocytic leukemia cell line HL60 through a new stable rearrangement product (1) when in the presence of FeSO(4). This conversion mechanism is different from another sesquiterpene endoperoxide lactone compound, dihydroartemisinin (DHA), which is an anti-malarial drug. The cytotoxicity of EDBD decreased in the presence of the ferrous ion chelating drug deferoxamine mesylate (DFOM), and this suggested that the structural change of the drug caused by Fe(2+) may be responsible for its biological activities. EDBD induced apoptosis via phosphorylation of p38 mitogen-activated protein kinase (MAPK) in HL60 cells, and was detected by Western blot. EDBD resulted in an immediate increase in DCF fluorescence intensity in HL60 cells using DCFH-DA (2',7'-dichlorofluorescin diacetate) assay. The in vitro reaction of EDBD with FeSO(4) also increased DCF fluorescence intensity in a dose dependent manner. These results showed that the biological activity of EDBD involves an unstable carbon-centered radical intermediate. Furthermore, there was no similarity between the JFCR39 fingerprints of EDBD and DHA (correlation coefficient on COMPARE Analysis γ = 0.158). EDBD showed anti-tumor effects against a xenograft of Lox-IMVI cells in vivo.
Sujet(s)
Antinéoplasiques d'origine végétale/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Asteraceae/composition chimique , Tumeurs expérimentales/traitement médicamenteux , Plantes comestibles/composition chimique , Sesquiterpènes/pharmacologie , Animaux , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Prolifération cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Tests de criblage d'agents antitumoraux , Cellules HL-60 , Humains , Souris , Souris nude , Tumeurs expérimentales/anatomopathologie , Sesquiterpènes/composition chimique , Sesquiterpènes/isolement et purification , Relation structure-activitéRÉSUMÉ
Hydronephrosis induced in the kidney of neonatal mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via lactation is a sensitive and characteristic hallmark of TCDD teratogenicity. We previously found that cyclooxygenase-2 (COX-2) activity induced in mouse neonate kidneys by lactational TCDD exposure is required for this toxicity. COX-2 is an inducible form of cyclooxygenase and is responsible for producing prostaglandins (PGs) and thromboxane. PGE(2), a prostaglandin, is elevated in TCDD-exposed mouse pups. In this study, we investigated the role of microsomal prostaglandin E synthase-1 (mPGES-1), an inducible form of PGE(2) synthase, in TCDD-induced hydronephrosis. A dose of 10 µg TCDD/kg to dams increased mPGES-1 messenger RNA abundance, urinary PGE(2) levels, and the incidence of hydronephrosis in mPGES-1 wild-type pups. In homozygous mPGES-1 knockout (KO) mice, in contrast, TCDD-induced hydronephrosis was suppressed, demonstrating an essential role of mPGES-1 in the response. Lack of the mPGES-1 gene also suppressed urinary PGE(2) level to near the basal level in TCDD-exposed pups. In conclusion, mPGES-1 upregulation upon lactational TCDD exposure is a causal factor for TCDD-induced hydronephrosis in mouse neonates.
Sujet(s)
Hydronéphrose/induit chimiquement , Intramolecular oxidoreductases/métabolisme , Rein/effets des médicaments et des substances chimiques , Lactation , Exposition maternelle , Dibenzodioxines polychlorées/toxicité , Animaux , Animaux nouveau-nés , Dinoprostone/urine , Femelle , Hydronéphrose/enzymologie , Hydronéphrose/génétique , Hydronéphrose/prévention et contrôle , Intramolecular oxidoreductases/déficit , Intramolecular oxidoreductases/génétique , Rein/enzymologie , Souris , Souris de lignée C57BL , Souris knockout , Prostaglandin-E synthases , ARN messager/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Régulation positiveRÉSUMÉ
Pyrrospirones A and B have been isolated from unpolished rice cultures of the endophytic fungus Neonectria ramulariae Wollenw KS-246. Their absolute stereostructures (1 and 2) were elucidated through spectroscopic methods using 1D and 2D NMR techniques and chemical transformations, including the modified Mosher's method. The compounds exhibited cytotoxicity and induced apoptosis in human promyelocytic leukemia HL-60 cells.